[an error occurred while processing this directive]
en

Study on the relationship between the expression of BPI gene and Escherichia coli F18 infection in piglets

Expand
  • 1. Animal Science and Technology College, Yangzhou University, Key Laboratory for Animal Genetics, Breeding, Reproduction and Molecular Design of Jiangsu Province, Yangzhou 225009, China 2. College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China 3. Jiangsu Engineering Research Centre for Molecular Breeding of Breeder Pig, Changzhou 213149, China 4. Jiangsu (Yangzhou) Public Technical Service Centre for Efficient and Healthy Culture Technology in Large-scale Swine Farms, Yangzhou 225009, China

Received date: 2011-01-07

  Revised date: 2011-05-11

  Online published: 2011-11-25

Abstract

Based on the established resource populations of Sutai pig, the expression of BPI gene was assayed by Real-time PCR to detect the tissue expression and analyze the differential expression between Escherichia coli F18-resistant and sensitive piglets. This study aimed at providing a theoretical foundation for further research on the role BPI gene in host immunity and resistance to E. coli F18. The results showed that the expression of BPI gene was extremely low or undetectable in tissues including heart, liver, spleen, lung, kidney, stomach, muscle, thymus, and lymph nodes, which was in a stark contrast to the significantly high levels in duodenum and jejunum. In the tissues of both jejunum and duodenum, the mRNA expression of BPI gene in resistant individuals was significant higher than that in the sensitive individuals (P<0.05). The results suggested that BPI gene was likely to be related to the intestinal infection caused by E. coli F18. It is possible that the increased expression of BPI gene in intestinal is in connection with the resistance to E. coli F18.

Cite this article

YE Lan, ZI Chen, LIU Lu, ZHU Jing, XIE Kai-Zhou, ZHU Guo-Qian, HUANG Xiao-Guo, BAO Wen-Bin . Study on the relationship between the expression of BPI gene and Escherichia coli F18 infection in piglets[J]. Hereditas(Beijing), 2011 , 33(11) : 1225 -1230 . DOI: 10.3724/SP.J.1005.2011.01225

References

[1] Weiss J, Muello K, Victor M, Elsbach P. The role of lipopolysaccharides in the action of the bactericidal/ permeability-increasing neutrophil protein on the bacterial envelope. J Immunol, 1984, 132(6): 3109-3115.
[2] Capodici C, Chen S, Sidorczyk Z, Elsbach P, Weiss J. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli. Infect Immun, 1994, 62(1): 259-265.
[3] Wilde CG, Seilhamer JJ, McGrogan M, Ashton N, Snable JL, Lane JC, Leong SR, Thornton MB, Miller KL, Scott RW. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation. J Biol Chem, 1994, 269(26): 17411-17416.
[4] Iovine NM, Elabach P, Weiss J. An opsonic function of the neutrophil bactericidal/permeability increasing protein depends on both its N- and C-terminal domains. Proc Natl Acad Sci USA, 1997, 94(20): 10973-10978.
[5] van der Schaft DW, Toebes EA, Haseman JR, Mayo KH, Griffioen AW. Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells. Blood, 2000, 96(1): 176-181.
[6] Newman SL, Gootee L, Gabay JE, Selsted ME. Identifica-tion of constituents of human neutrophil azurophil gran-ules that mediate fungistasis against Histoplasma capsulatum. Infect Immun, 2000, 68(10): 5668-5672.
[7] Khan AA, Lambert LH Jr, Remington JS, Araujo FG. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii. Antimicrob Agents Chemother, 1999, 43(4): 758-762.
[8] 周红, 郑江, 肖光夏. 猪源杀菌性/通透增加蛋白对革兰氏阴性菌的作用. 中华传染病杂志, 1992, 17(1): 47-48.
[9] 周红, 袁建成, 周立新, 郑江, 萧光夏. 杀菌性/通透性增加蛋白中和内毒素作用的体内外研究. 中华医学杂志, 1999, 79(4): 304-305.
[10] 周红, 郑江, 秦孝建, 萧光夏. 抗人BPI抗体对猪源BPI体外生物活性的增强作用. 第三军医大学学报, 2002, 24(1): 76-78.
[11] 袁树楷. 荣昌猪BPI基因全长cDNA克隆及SNP分析[学位论文]. 重庆: 西南大学, 2007.
[12] 曹晓华. 四个猪种间BPI蛋白基因外显子3和4的SNP分析[学位论文]. 重庆: 西南大学, 2008.
[13] Tuggle, CK, Thomas JS, Shi XW, Martha AM. Genetic markers for improved disease resistance in animals (BPI). United States Department of Agriculture patents. 2006 no. US 7,070,929 B2, 36 p.
[14] Da Silva AS, Valadares GF, Penatti MPA, Brito BG, Da Silva LD. Escherchia coli strains from edema dis-ease: O serogroups, and genes for Shiga toxin, enterotoxins, and F18 fimbriae. Vet Microbiol, 2001, 80(3): 227-233.
[15] Meijerink E, Fries R, Vögeli P, Masabanda J, Wigger G, Stricker C, Neuenschwander S, Bertschinger HU, Stranzinger G. Two α (1,2) fucosyltransferase genes on porcine chromosome 6q11 are closely linked to the blood group in-hibitor (S) and Escherichia coli F18 receptor (ECF18R) Loci. Mamm Genome, 1997, 8(10): 736-741.
[16] Vögeli P, Meijerink E, Fries R, Neuenschwander S, Vorländer N, Stranzinger G, Bertschinger HU. A molecular test for the detection of E. coli F18 receptors: a Breakthrough in the struggle against edema disease and post-weaning diarrhea in swine. Schweiz Arch Tierheilkd, 1997, 139(11): 479-484.
[17] 吴圣龙, 原志伟, 鞠慧萍, 黄雪根, 华金弟, 沈家林, 周冠月, 王建业, 谢恺舟, 陈国宏, 朱国强. 苏太仔猪FUT1基因M307位点多态性与F18大肠杆菌抗病相关性的体外鉴定. 中国预防兽医学报, 2007, 29(10): 783-787.
[18] Weiss J, Beckerdite-Quagliata S, Elsbach P. Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure. J Clin Invest, 1980, 65(3): 619-628.
[19] Mannion BA, Weiss J, Elsbach P. Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli. J Clin Invest, 1990, 86(2): 631-641.
[20] Takahashi M, Horiuchi Y, Tezuka T. Presence of bacterici
Outlines

/